Trial · NCT07898189
A Study to Evaluate the Effects of a Supplement on Gut Comfort in GLP-1 Receptor Agonist Users
NCT07898189, Not applicable, Completed, AB Mauri (UK) Limited,
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Study to Evaluate the Effects of a Supplement on Gut Comfort in GLP-1 Receptor Agonist Users. Trials, record NCT07898189. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07898189
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study to Evaluate the Effects of a Supplement on Gut Comfort in GLP-1 Receptor Agonist Users
- NCT number
- NCT07898189
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 70 participants, actual
- Lead sponsor
- AB Mauri (UK) Limited,
- Conditions
- Gastrointestinal Discomfort, Gastrointestinal Side Effects of GLP-1 Receptor Agonist Use, Nausea, Abdominal Pain, Bloating, Diarrhea, Constipation
- Interventions
- Placebo, Oxxynea® Supplement
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Gastrointestinal Comfort and Gut Health | Baseline, Week 2, Week 4, and Week 6 | Mean change in the GI symptom subscale of the Gastrointestinal Quality of Life Index (GIQLI) score from Baseline |
| Secondary | Change in Physical Functioning | Baseline, Week 2, Week 4, and Week 6 | Mean change in the GIQLI items corresponding to Physical Functioning (part of the 16-item Physical Functioning, Emotional Well-being, and Social Functioning subscale) from Baseline |
| Secondary | Change in Emotional Well-being | Baseline, Week 2, Week 4, and Week 6 | Mean change in the GIQLI items corresponding to Emotional Well-being (part of the 16-item Physical Functioning, Emotional Well-being, and Social Functioning subscale) from Baseline |
| Secondary | Change in Social Functioning | Baseline, Week 2, Week 4, and Week 6 | Mean change in the GIQLI items corresponding to Social Functioning (part of the 16-item Physical Functioning, Emotional Well-being, and Social Functioning subscale) from Baseline |
| Secondary | Change in Participant-Perceived Effects of Medical Treatment | Baseline, Week 2, Week 4, and Week 6 | Mean change in the GIQLI item corresponding to Effects of Medical Treatment from Baseline |
| Secondary | Change in Nausea | Daily for Days 1-14 | Mean change in the GIQLI nausea item score, assessed via an adapted version of the GIQLI questionnaire |
| Secondary | Change in Abdominal Pain | Daily for Days 1-14 | Mean change in the GIQLI abdominal pain item score, assessed via an adapted version of the GIQLI questionnaire |
| Secondary | Change in Bloating | Daily for Days 1-14 | Mean change in the GIQLI bloating item score, assessed via an adapted version of the GIQLI questionnaire |
| Secondary | Change in Diarrhea | Daily for Days 1-14 | Mean change in the GIQLI diarrhea item score, assessed via an adapted version of the GIQLI questionnaire |
| Secondary | Change in Constipation | Daily for Days 1-14 | Mean change in the GIQLI constipation item score, assessed via an adapted version of the GIQLI questionnaire |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07898189
GET https://conductscience.org/api/trials/v1/NCT07898189/registered